Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment

Tomoyuki Oshio, Yasuharu Sasaki, Megumi Tago, Eriko Yokota, Yoshiko Sonoda, Hiroyuki Matsuoka, Tadashi Kasahara

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease, which is accompanied by marked increases in the levels of inflammatory cells, including mast cells and eosinophils as well as T cells and macrophages. To investigate the expression pattern of chemokines in AD, a house dust mite, Dermatophagoides farinae extracts (DfE)-induced NC/Nga AD model was developed in mice, and this model was used to determine the expression levels of chemokines in atopic lesions using DNA microarrays and RT-PCR. When NC/Nga mice were repeatedly treated with DfE for 4 to 7 weeks on the back skin, the mRNA expression levels of CCL20/LARC, CCL24/eotaxin-2, CCL17/TARC, and CCL11/eotaxin-1 were markedly induced and lesser of CCL2/MCP-1, within the inflammatory lesion of the back skin. Immunohistochemical staining revealed the expression of these chemokines in the epidermis and dermis of DfE-treated NC/Nga mice. Interestingly, repeated application of tacrolimus ointment potently inhibited DfE-induced atopic dermatitis in NC/Nga mice concomitant with the inhibition of these changes in chemokine gene and protein expression levels particularly of CCL20/LARC, CCL17/TARC, and CCL11/eotaxin-1. These data indicate that severe atopic dermatitis induced by DfE accompanies elevated chemokine levels, and it was proposed that tacrolimus ointment is beneficial for the treatment of severe AD.

Original languageEnglish
Pages (from-to)403-411
Number of pages9
JournalInternational Immunopharmacology
Volume9
Issue number4
DOIs
Publication statusPublished - 2009 Apr

Fingerprint

Dermatophagoides farinae
Tacrolimus
Atopic Dermatitis
Ointments
Chemokines
Chemokine CCL11
Chemokine CCL24
Pyroglyphidae
Skin
Dermis
Oligonucleotide Array Sequence Analysis
Skin Diseases
Eosinophils
Epidermis
Mast Cells
Macrophages
Staining and Labeling
T-Lymphocytes
Gene Expression
Polymerase Chain Reaction

Keywords

  • Atopic dermatitis
  • Chemokines
  • Dermatophagoides farinae
  • NC/Nga
  • Tacrolimus ointment/protopic

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment. / Oshio, Tomoyuki; Sasaki, Yasuharu; Tago, Megumi; Yokota, Eriko; Sonoda, Yoshiko; Matsuoka, Hiroyuki; Kasahara, Tadashi.

In: International Immunopharmacology, Vol. 9, No. 4, 04.2009, p. 403-411.

Research output: Contribution to journalArticle

@article{1ae4f1b12f19420db6d7c4b53d710a43,
title = "Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment",
abstract = "Atopic dermatitis (AD) is a chronic inflammatory skin disease, which is accompanied by marked increases in the levels of inflammatory cells, including mast cells and eosinophils as well as T cells and macrophages. To investigate the expression pattern of chemokines in AD, a house dust mite, Dermatophagoides farinae extracts (DfE)-induced NC/Nga AD model was developed in mice, and this model was used to determine the expression levels of chemokines in atopic lesions using DNA microarrays and RT-PCR. When NC/Nga mice were repeatedly treated with DfE for 4 to 7 weeks on the back skin, the mRNA expression levels of CCL20/LARC, CCL24/eotaxin-2, CCL17/TARC, and CCL11/eotaxin-1 were markedly induced and lesser of CCL2/MCP-1, within the inflammatory lesion of the back skin. Immunohistochemical staining revealed the expression of these chemokines in the epidermis and dermis of DfE-treated NC/Nga mice. Interestingly, repeated application of tacrolimus ointment potently inhibited DfE-induced atopic dermatitis in NC/Nga mice concomitant with the inhibition of these changes in chemokine gene and protein expression levels particularly of CCL20/LARC, CCL17/TARC, and CCL11/eotaxin-1. These data indicate that severe atopic dermatitis induced by DfE accompanies elevated chemokine levels, and it was proposed that tacrolimus ointment is beneficial for the treatment of severe AD.",
keywords = "Atopic dermatitis, Chemokines, Dermatophagoides farinae, NC/Nga, Tacrolimus ointment/protopic",
author = "Tomoyuki Oshio and Yasuharu Sasaki and Megumi Tago and Eriko Yokota and Yoshiko Sonoda and Hiroyuki Matsuoka and Tadashi Kasahara",
year = "2009",
month = "4",
doi = "10.1016/j.intimp.2008.12.013",
language = "English",
volume = "9",
pages = "403--411",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment

AU - Oshio, Tomoyuki

AU - Sasaki, Yasuharu

AU - Tago, Megumi

AU - Yokota, Eriko

AU - Sonoda, Yoshiko

AU - Matsuoka, Hiroyuki

AU - Kasahara, Tadashi

PY - 2009/4

Y1 - 2009/4

N2 - Atopic dermatitis (AD) is a chronic inflammatory skin disease, which is accompanied by marked increases in the levels of inflammatory cells, including mast cells and eosinophils as well as T cells and macrophages. To investigate the expression pattern of chemokines in AD, a house dust mite, Dermatophagoides farinae extracts (DfE)-induced NC/Nga AD model was developed in mice, and this model was used to determine the expression levels of chemokines in atopic lesions using DNA microarrays and RT-PCR. When NC/Nga mice were repeatedly treated with DfE for 4 to 7 weeks on the back skin, the mRNA expression levels of CCL20/LARC, CCL24/eotaxin-2, CCL17/TARC, and CCL11/eotaxin-1 were markedly induced and lesser of CCL2/MCP-1, within the inflammatory lesion of the back skin. Immunohistochemical staining revealed the expression of these chemokines in the epidermis and dermis of DfE-treated NC/Nga mice. Interestingly, repeated application of tacrolimus ointment potently inhibited DfE-induced atopic dermatitis in NC/Nga mice concomitant with the inhibition of these changes in chemokine gene and protein expression levels particularly of CCL20/LARC, CCL17/TARC, and CCL11/eotaxin-1. These data indicate that severe atopic dermatitis induced by DfE accompanies elevated chemokine levels, and it was proposed that tacrolimus ointment is beneficial for the treatment of severe AD.

AB - Atopic dermatitis (AD) is a chronic inflammatory skin disease, which is accompanied by marked increases in the levels of inflammatory cells, including mast cells and eosinophils as well as T cells and macrophages. To investigate the expression pattern of chemokines in AD, a house dust mite, Dermatophagoides farinae extracts (DfE)-induced NC/Nga AD model was developed in mice, and this model was used to determine the expression levels of chemokines in atopic lesions using DNA microarrays and RT-PCR. When NC/Nga mice were repeatedly treated with DfE for 4 to 7 weeks on the back skin, the mRNA expression levels of CCL20/LARC, CCL24/eotaxin-2, CCL17/TARC, and CCL11/eotaxin-1 were markedly induced and lesser of CCL2/MCP-1, within the inflammatory lesion of the back skin. Immunohistochemical staining revealed the expression of these chemokines in the epidermis and dermis of DfE-treated NC/Nga mice. Interestingly, repeated application of tacrolimus ointment potently inhibited DfE-induced atopic dermatitis in NC/Nga mice concomitant with the inhibition of these changes in chemokine gene and protein expression levels particularly of CCL20/LARC, CCL17/TARC, and CCL11/eotaxin-1. These data indicate that severe atopic dermatitis induced by DfE accompanies elevated chemokine levels, and it was proposed that tacrolimus ointment is beneficial for the treatment of severe AD.

KW - Atopic dermatitis

KW - Chemokines

KW - Dermatophagoides farinae

KW - NC/Nga

KW - Tacrolimus ointment/protopic

UR - http://www.scopus.com/inward/record.url?scp=61649125989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61649125989&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2008.12.013

DO - 10.1016/j.intimp.2008.12.013

M3 - Article

VL - 9

SP - 403

EP - 411

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 4

ER -